Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Blend Labs (BLND) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Blend Labs (BLND) over the last 6 years, with Q3 2025 value amounting to $55.0 million.

  • Blend Labs' Cash & Equivalents rose 880.17% to $55.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.0 million, marking a year-over-year increase of 880.17%. This contributed to the annual value of $38.0 million for FY2024, which is 2261.61% up from last year.
  • Per Blend Labs' latest filing, its Cash & Equivalents stood at $55.0 million for Q3 2025, which was up 880.17% from $36.5 million recorded in Q2 2025.
  • In the past 5 years, Blend Labs' Cash & Equivalents registered a high of $369.7 million during Q2 2021, and its lowest value of $31.0 million during Q4 2023.
  • Its 5-year average for Cash & Equivalents is $121.2 million, with a median of $77.6 million in 2024.
  • As far as peak fluctuations go, Blend Labs' Cash & Equivalents soared by 499755.96% in 2021, and later tumbled by 7504.01% in 2023.
  • Blend Labs' Cash & Equivalents (Quarter) stood at $213.1 million in 2021, then plummeted by 41.71% to $124.2 million in 2022, then plummeted by 75.04% to $31.0 million in 2023, then rose by 22.62% to $38.0 million in 2024, then surged by 44.75% to $55.0 million in 2025.
  • Its Cash & Equivalents was $55.0 million in Q3 2025, compared to $36.5 million in Q2 2025 and $56.2 million in Q1 2025.